The purpose of this study was to validate the detection of clinically significant prostate cancer in patients with serum PSA > 4.0 ng/ml by PI-RADS v2 and to assess the ability of quantitative MRI parameters to both detect and grade clinically significant prostate cancer in an Indian demographic. This evidence concerns the gene KLK3 and Familial prostate cancer.